Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for FTRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 19.90M
March 31, 2026 -25.00M
December 31, 2025 121.60M
September 30, 2025 79.50M
June 30, 2025 14.30M
March 31, 2025 -127.10M
December 31, 2024 20.30M
September 30, 2024 -10.60M
June 30, 2024 262.50M
Date Value
March 31, 2024 -34.90M
December 31, 2023 9.00M
September 30, 2023 -3.20M
June 30, 2023 140.50M
March 31, 2023 -18.20M
December 31, 2022 9.90M
September 30, 2022 63.90M
June 30, 2022 31.30M
March 31, 2022 -72.00M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Charles River Laboratories International, Inc. 148.62M
IQVIA Holdings, Inc. 360.00M
Medpace Holdings, Inc. 138.10M
Personalis, Inc. -29.55M
10X Genomics, Inc. 15.39M